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Abstract: In differentiated thyroid carcinoma (DTC) with primary tumor smaller than 1 cm, the routine central
lymph node (LN) dissection is questioned, due to increased risk of post-surgery complications and lack of
confirmed benefit.
Aim: The analysis of prognostic significance of LN metastases, in DTC patients to verify the potential role of central
neck lymphadenectomy on disease staging.
Materials and methods: The group of 195 DTC patients, primarily operated between 2004 and 2005, was
retrospectively analyzed. 184 patients after radical operation, with no distant metastases diagnosed before surgery,
were included into analysis. LN metastases were observed in 55 of cases (28%). In 124 cases only dissection of
central LN compartment was performed, in 36 patients also uni- or bilateral modified cervical lymphadectomy was
carried out. In 24 patients with tumor limited to the thyroid gland without suspicious lymph nodes, the routine
central lymph node dissection was not done.
Results: Median follow-up was 4 years. The 5-year overall and disease free survival standardized ratio were 100%
and 95% respectively. The risk of LN metastases increased with the more locally advanced cancer. In the group of
124 patients, in whom only central LN dissection was performed, LN metastases were diagnosed in 15 cases (12%).
No significant relation between multifocality and frequency of central and/or lateral LN metastases was noticed.
Significant correlation between N feature and extrathyroidal invasion was observed (p = 0,0003). The presence of
LN metastases was related to worsening of disease free survival from 99 to 90%. During the follow-up recurrence
occurred in 6 (3%) cases. In 24 patients in whom only total thyroidectomy was done, no local or distant recurrence
was observed. The assessment of early postoperative complications (hypoparathyroidism, paresis of vocal cords)
indicated that the frequency of early calcium balance disturbances was significantly lower in patients in whom
central LN dissection was not performed (p = 0,04)
Conclusions: Our result indicate that in the early diagnosis of thyroid cancer, the occurrence of LN DTC
metastases is rarer and was observed only in 12% of elective dissections of central LN node compartment, if no
lateral dissection was indicated due to the lack of clinical suspicion. In DTC patients with tumor diameter <1 cm
and no sonographical or inraoperative suspicion on LN involvement, routine central lymphadenectomy may be not
obligatory.
* Correspondence: jkrajewska@io.gliwice.pl
M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,
Gliwice Branch, Gliwice, Poland
Czarniecka et al. Thyroid Research 2010, 3:8
http://www.thyroidresearchjournal.com/content/3/1/8
© 2010 Czarniecka et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Introduction
The optimal extent of surgical approach related to cervi-
cal lymph nodes in DTC is still discussed. Up to now
there is no agreement whether cervical lymph node
metastases (N feature) are related to a worse prognosis
in DTC patients, when only central lymph nodes or uni-
lateral lateral lymph nodes are involved and the extent
of lymphadenectomy is sufficient. Some data confirm
the importance of this prognostic factor, its influence
both on overall and disease free survival [1-5]. However,
some data demonstrate its implication related to cancer
relapse only [6-8] whereas other neglect its prognostic
value [9-11]. Obviously, the issue is more important in
papillary thyroid cancer (PTC) where lymph node
metastases occur more frequently than in follicular thyr-
oid cancer (FTC). Papers published in the recent years
more and more frequently recommend the limited
extent of central compartment lymph node dissection in
very low risk DTC patients due to a higher risk of post-
surgical complications as well as to the lack of con-
firmed benefit [12-17]. Thus, it seems that, to plan an
optimal, stage-dependent extent of surgery, the signifi-
cance of this factor should be taken into consideration.
The actual guidelines concerning DTC treatment
recommend total thyroidectomy together with central
compartment (group VI) dissection in almost all DTC
patients. Lateral neck lymphadenectomy (group II - V)
is indicated only if the presence of lymph node metas-
tases is proven by preoperative FNA or by open biopsy
during the surgery or, at least, clinically suspected. In
the recent years there are more and more data suggest-
ing the possibility of safe resignation of the routine cen-
tral compartment dissection in low risk DTC [12-17].
The rationale for this is related to higher risk of post-
operative complications depending on the extent of sur-
gery (recent studies revealed higher ratio of early
complications than it was previously observed). Simulta-
neously, no higher risk of relapse or cancer-related
death was observed [12-17].
The aim of the study
A retrospective analysis of the prognostic impact of
lymph node metastases, particularly of the central neck
compartment, in DTC patients.
Materials and methods
The group of 195 DTC patients, primarily operated
between 2004 and 2005 in Oncological Surgery Clinic in
Gliwice, were retrospectively analyzed. In 185 radical
operation (R0 resection) was carried out whereas in 10
non-radical approach (R2 resection) was performed due to
a locally advanced disease. Distant metastases were
diagnosed in 10 (5%) patients, among them in 7 (4%)
preoperatively.
184 DTC patients who received radical operation, with
no distant metastases diagnosed before surgery, were
included into further, more detailed analysis. One sub-
ject with poorly differentiated thyroid cancer was
excluded. The study group consisted of 160 (87%)
women and 24 (13%) men, mean age 46 years (median
46 yrs). Primary total thyroidectomy was carried out in
all patients. Among them there were 178 PTC (97%)
and 6 (3%) FTC cases. 115 patients were in pT1 stage
(63%), 29 in pT2 (16%), 34 in pT3 (18%) and 6 in pT4
(3%) (according to the UICC classification 2002). The
extent of lymph node dissection is presented in Table 1.
Lymph node metastases were observed in 51 (28%)
(Table 2). Complementary radioiodine therapy was indi-
cated in all patients routinely.
Mean and median follow-up was 4 yrs.
Statistical analysis was carried out by the use of SPSS
12 software. The chi2 test and Kaplan-Meyer survival
analysis were performed.
Results
The 5-year overall and disease free survival standardized
ratio were 100% and 95% respectively. The presence of
lymph node metastases was related to worsening of dis-
ease free survival from 99 to 90% and the difference was
statistically significant (p = 0,002, Figure 1).
The risk of lymph node metastases increased with the
more locally advanced cancer. The lowest ratio of lymph
node involvement, 19%, was observed in pT1 DTC
patients (tumor diameter ≤2 cm) (Table 2). Definitely,
lymph node metastases coexisted most commonly with
extracapsular invasion in pT3 and pT4 (55%) tumors.
Significant correlation between N feature and extrathyr-
oidal invasion was observed (p = 0,0003). Multifocal
cancer growth was present in 47 (26%) subjects. How-
ever, no significant relation between multifocality and
frequency of lymph node metastases was noticed.
During the follow-up cancer recurrence occurred in 6
(3%) subjects, 5 of them were from N1 subgroup. Local
relapse in 2 of them, whereas in 4 distant metastases
were diagnosed.
Table 1 Extent of lymph nodes operations
Extent of lymph node operations Number of
patients
Frequency
No lymph node dissection 24 13%
Only central lymph node dissection
(group VI)
124 67%
Central + unilateral cervical dissection 32 18%
Central + bilateral cervical dissection 4 2%
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In the subgroup of 124 patients, in whom only central
lymph node dissection was performed, lymph node
metastases were diagnosed in 15 cases (12%). There
were 6 pT1 subjects, 2 pT2 and 7 pT3 in this group.
The tumor diameter smaller than 1 cm was not
observed in any pT1 patient, in 1 patient the tumor dia-
meter was 1 cm, in another one 1.2 cm and in 4
patients 2 cm. In the subgroup of 124 patients who
received thyroidectomy and central lymphadenectomy, 2
cancer recurrences occurred, one local relapse in pT3N1
patient and 1 case of bone metastases revealed in whole
body scintigraphy after therapeutic dose of 131-I in
pT2N0 patient
In 24 patients with tumor limited to the thyroid (pT1
and pT2), with no suspicious lymph nodes during the
surgery, the routine central lymph node dissection was
not done. No recurrence was observed in this group.
The assessment of early postoperative complications
(hypoparathyroidism as well as paralysis or paresis of
vocal cords) during the first or the second day after the
surgery was also carried out. The frequency of early cal-
cium balance disturbances was significantly lower in
patients in whom lymph node dissection was not per-
formed (p = 0,04; Table 3.).
Discussion
The importance of lymph node metastases in DTC has
been discussed for many years. Our previous analysis,
carried out on numerous, representative for Polish
population group of 1141 DTC patients, showed that
the presence of lymph node metastases affected signifi-
cantly both disease free and overall survival during
10-year follow-up (p < 0,0001) [5]. Multivariate back-
ward stepwise regression analysis demonstrated that
lymph node metastases, against a background of other
independent factors, were related to an increase of the
risk of both cancer-related death and cancer relapse. In
patients with lymph node involvement the risk of can-
cer-related death grew more than 3 times (RR 3,16).
The risk of cancer recurrence was even higher - RR
4,48. Prospective randomized studies are lacking due to
DTC relatively long-term natural course. Thus, present
observational study is based on a retrospective analysis
of patients treated and followed up in a uniform way in
one center.
The influence of lymph node metastases on disease
free survival during the 5-year follow-up of DTC
patients was analyzed. The frequency of lymph node
metastases was correlated with the tumor diameter
(T feature). Lymph node involvement was observed
more often in patients with extrathyroid tumor invasion
(pT3 and pT4). Thus, resignation from central lymph
node dissection seems to be safe only in low advanced
PTC. However, central lymph node metastases were
found in 6 pT1 subjects in the group of 15 patients in
whom routine central neck lymphadenectomy revealed
the presence of central lymph node metastases. How-
ever, in none of them the tumor diameter was <1 cm.
Thus, at the beginning, it seems reasonable to restrict
the extent of the operation only in patients with papil-
lary microcarcinoma (intrathyroid tumor ≤1 cm) with-
out clinically suspicion of central lymph node
involvement. However, the cases of both central and lat-
eral lymph node metastases in DTC patients with tumor
<1 cm, particularly in children and young adults have to
be not missed. Thus, a careful pre- and intraoperative
evaluation of the suspected lymph nodes is necessary,
associated with a detailed analysis of all clinical factors.
This strategy has been adopted in our center and
among 39 tumors of <1 cm diameter diagnosed preo-
peratively central lymphadenectomy was decided in 15
cases and was positive in none of them.
Table 2 The frequency of lymph node (N) and distant (M)
metastases in relation to T stage
T stage Number of patients N1 Frequency M1 Frequency
T1 115 22 19% 0 0%
T2 29 8 27% 1 3%
T3 34 18 53% 3 9%
T4 6 3 50% 0 0%
Total 184 51 28% 4 2%
Figure 1 Analysis of 5 years disease-free survival in relation to
presence of neck lymph node metastases.
Table 3 Frequency of early postoperative complications














20 (11%) 10 (10%) 0 (0%) n.s.
Hypoparathyroidism 37 (20%) 29 (23%) 1 (4%) p =
0,04
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In no subject from the pilot group of 24 DTC
patients, in whom routine central neck dissection was
not done, cancer recurrence was diagnosed. On the
other hand, clearly lower incidence of early postopera-
tive complications was stated in this group, statistically
significant as far as calcium-phosphorous balance is
concerned [Table 3]. Similar observation was reported
by Palestini at al. In the group of 64 patients after total
thyroidectomy with bilateral central lymphadenectomy
the laryngeal recurrent nerve paresis was present in
5 (7,8%) subjects, whereas hypoparathyroidism in
20 (31%). In the group of 93 subjects after total thyroi-
dectomy with unilateral central lymphadenectomy (on
the tumor side) these complications concerned 5 (5,4%)
and 25 (27%) patients, respectively. The lowest compli-
cation ratio was observed in the group of 148 patients
in whom only total thyroid resection was carried out -
laryngeal recurrent nerve paresis in 13 (9%) and hypo-
parathyroidism in 19 (13%) cases. The authors reported
statistically significant difference in frequency of cal-
cium-phosphorus balance disturbances depending on
the extent of the surgery (p = 0,003) [17].
Due to the number of patients and follow-up period
our study should be considered as an initial report.
However, it seems that after proper selection in some
cases routine central lymph node dissection may and
should be avoided. According to the Italian authors aim-
ing restriction of the parathyroid vascular shock in justi-
fied cases unilateral central lymphadenectomies (on the
tumor side) may be performed, even in more advanced
stages [17].
Probably, the cancer expansion ability (lymph node and
distant metastasis) is related not only to its local advance-
ment or tumor diameter but also to its molecular profile.
Perhaps, the future evaluation of DTC molecular profile
and its metastasizing ability may lead to a better planning
of the treatment approach [18]. Unfortunately, up to now
this decision is based on clinical and pathological features
only.
Conclusions
Our result indicate that in the last years, with the early
diagnosis of thyroid cancer, the occurrence of lymph
node DTC metastases is rarer and was observed only in
12% of elective dissections of central neck lymph node
compartment, if no lateral dissection was indicated due
to the lack of clinical suspicion. In DTC patients with
tumor diameter <1 cm and no sonographical or inrao-
perative suspicion on lymph node involvement, routine
central lymphadenectomy may be not obligatory.
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